Chengdu shengnuo biotechnologypharmaceutical Co., Ltd., a subsidiary of Chengdu Shengnuo Technology Development Co., Ltd., was established in October 2004 as a high-tech certification enterprise in Sichuan Province with a registered capital of 45 million yuan;
There are 228 employees. It has more than 50 key technologies of peptide scale production that have been listed at home and abroad. It is a first-class international enterprise specialized in peptide and amino acid drugs scale production in China, with single batch output of kg, and is a leader in domestic peptide industry. The company has passed FDA certification.
Chengdu shengnuo biotechnology IPO held a meeting, and it is the eighth listed enterprise on science and technology innovation board in Sichuan this year
On December 11, Chengdu shengnuo biotechnologytechnology Co., Ltd. (hereinafter referred to as “shengnuo biotechnology”) issued shares for the first time, and its application for listing on the science and technology innovation board was approved by the Shanghai municipal Party committee.
It is also the eighth enterprise in Sichuan that passed the meeting on the science and technology innovation board. According to the prospectus, shengnuo biotechnology is a high-tech enterprise with the core technology of peptide synthesis and modification.
Its main business includes providing pharmaceutical research and customized production services for the research and development of peptide innovative drugs for domestic and foreign pharmaceutical enterprises, independent research and development, production and sales of peptide generic raw materials and preparations with large market capacity and strong competitiveness at home and abroad, as well as pharmaceutical products Peptide drug production technology transfer services.
In addition, the company is also engaged in the processing of levosimendan preparations and the production and export of levosimendan raw materials.
According to the financial data, from 2017 to the first half of 2020, the operating revenue of the company was 194 million yuan, 278 million yuan, 327 million yuan and 176 million yuan respectively, and the corresponding net profit in the same period was 33.9004 million yuan, 29.8613 million yuan, 48.1317 million yuan and 31.3111 million yuan respectively.
shengnuo biotechnology plans to raise 349 million yuan this time, which is mainly used for 395 kg / a peptide API production line project, preparation industrialization technology transformation project and Engineering Technology Center upgrading project.
Other Polypeptide APIs Products
peptide synthesis companies
| Polypeptide APIs Products |
| US-DMF LIST |
| Beauty peptides |
| Chinese cGMP APIs |
| Mexico Registered APIs |
| Research Peptide APIs for Regulatory Market |
| Polypeptide Preparation |
| Kaijie bio medicine Peptide APIs |
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
There are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.